Trial · NCT07128394
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
NCT07128394, Not applicable, Recruiting, Nanjing University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment. Trials, record NCT07128394. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07128394
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
- NCT number
- NCT07128394
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 590 participants, estimated
- Lead sponsor
- Nanjing University
- Conditions
- Infertility, Female, Luteinizing Hormone (LH)
- Interventions
- Recombinant Luteinizing Hormone (rLH), Recombinant Follicle-Stimulating Hormone (rFSH), Gonadotropin-Releasing Hormone Agonist (GnRH-a)
- First posted
- 2025-08-19
- Last updated
- 2025-08-19
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of cycles with no usable embryos | 7 days after oocyte retrieval | The number of IVF/ICSI cycles with no transferable embryos divided by the total number of oocyte retrieval cycles, evaluated based on embryo morphology and grading on Day 3 or Day 5-6 after fertilization. |
| Secondary | Number of high-quality Day 3 embryos | 7 days after oocyte retrieval | Count of embryos meeting morphological criteria for high quality on Day 3 after fertilization, as determined by standard embryology scoring. |
| Secondary | Total gonadotropin dose used | At the end of ovarian stimulation (average 8-12 days) | Cumulative dose (IU) of gonadotropins administered from stimulation start to trigger day. |
| Secondary | Duration of gonadotropin stimulation | At the end of ovarian stimulation (average 8-12 days) | Number of days from gonadotropin initiation to trigger day. |
| Secondary | Number of oocytes retrieved | At oocyte retrieval (36-38 hours after trigger) | Total number of oocytes collected during transvaginal ultrasound-guided oocyte retrieval. |
| Secondary | Clinical pregnancy rate | 30 days after embryo transfer | Proportion of embryo transfer cycles resulting in at least one intrauterine gestational sac with fetal heartbeat, confirmed by transvaginal ultrasound. |
| Secondary | Early miscarriage rate | Within 12 weeks of gestation | Proportion of clinical pregnancies ending in miscarriage before 12 completed weeks of gestation. |
| Secondary | Live birth rate | At delivery (up to 1 year after embryo transfer) | Proportion of embryo transfer cycles resulting in the delivery of at least one live-born infant. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers10
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07128394
GET https://conductscience.org/api/trials/v1/NCT07128394/registered